Immune enhancement for immunological non-responders to ART
Immune enhancement for immunological non-responders to ART
批准号:
8445018
负责人:
David Marshall Guidot
金额:
$47.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-26 至 2014-06-30
关键词:
Acquired Immunodeficiency SyndromeAddressAgeAlcohol consumptionAlveolarAlveolar MacrophagesAnti-Retroviral AgentsAntioxidantsBacteriaBiochemistryBiological AvailabilityBiologyBronchoalveolar LavageCD4 Positive T LymphocytesCardiovascular DiseasesCell CountChronicChronic lung diseaseClinicalClinical InvestigatorClinical ResearchClinical TrialsDevelopmentDietary SupplementationDietary ZincDiseaseDoseEquilibriumExhalationExperimental ModelsFailureGenomicsGlutathioneGoalsHIVHIV-1HealthHealthcareHighly Active Antiretroviral TherapyImmuneImmune responseImmunityIncidenceIndividualInfectionLungMeasurementMental DepressionMonitorMorbidity - disease rateNatural ImmunityOutcomeOxidation-ReductionOxidative StressPeripheralPlayPneumoniaPredispositionProteinsQualifyingResearchResourcesRiskRisk FactorsRoleS-AdenosylmethionineScientistSeveritiesSocietiesStagingSulfhydryl CompoundsSupplementationTechniquesTestingTranslatingTreatment EfficacyUniversitiesViralVirus DiseasesVulnerable PopulationsWashingtonZincZinc deficiencychronic alcohol ingestioncohortefficacy testinghigh riskimmune functionimprovedinnate immune functionkillingsmacrophagemetabolomicsmortalitymultidisciplinarynoveloutcome forecastresearch studyresponserestorationtherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This new proposal entitled "Immune enhancement for immunological non-responders to ART" details a novel clinical trial of dietary zinc and S-adenosylmethionine (SAMe) supplementation in individuals infected with the human immunodeficiency virus (HIV) who do not respond adequately to anti-retroviral therapy (ART). Specifically, approximately 35% of HIV-infected individuals who are treated with appropriate doses of ART and achieve virological control nevertheless do not recover a healthy immune response and remain at high risk for lung infections and chronic lung diseases, and have worse overall health outcomes. The mechanisms underlying this high failure rate are unknown, but older age and chronic alcohol use are associated with increased risk of immunological non-responsiveness. HIV infection is associated with zinc deficiency and oxidative stress, and we have compelling experimental and clinical evidence that these factors are particularly problematic in the alveolar space where they impair host immune functions in the alveolar macrophage. Specifically, otherwise healthy individuals with HIV infection or chronic alcohol ingestion have evidence of oxidative stress (as reflected by changes in thiol anti-oxidants such as glutathione), zinc deficiency, and impaired alveolar macrophage capacity to ingest and kill bacteria. Provocatively, treating these macrophages with zinc and/or glutathione improves their phagocytic capacity. In experimental models we have determined that dietary supplementation with zinc and/or glutathione precursors such as SAMe restore a healthy redox state and zinc bioavailability within the alveolar space and thereby normalize alveolar macrophage immune function. These studies are supported by other clinical evidence that zinc supplementation appears to decrease the progression of immune failure in HIV-infected individuals, and that SAMe supplementation has salutary effects on HIV-related depression. Taken together, the experimental and clinical evidence strongly argues that a combination of zinc and SAMe will restore redox and immune health in the airways of immunological non-responders, and could have salutary systemic immune effects as well. Using a multidisciplinary team that includes established clinical investigators in HIV clinical trials at Emory University and the University of
Washington, translational lung biology scientists, and sophisticated state-of-the-art research platforms in metabolomics, genomics, and redox biochemistry, we will assess both the lung-specific and the systemic responses to this therapy. Our larger goal is to identify novel features and/or mechanisms underlying immunological non-responsiveness and thereby develop and test therapies that can enhance the effects of ART and convert 'non-responders' to 'responders'. We have a uniquely qualified team that is focused on extending and improving the overall health of these individuals using targeted therapeutic approaches that are safe, simple, and feasible for broad delivery both in our society as well as in societies where healthcare resources are much scarcer.
PUBLIC HEALTH RELEVANCE: This new project entitled "Immune enhancement for immunological non-responders to ART" will test the hypothesis that long-term dietary supplementation with zinc and S-adenosylmethionine (SAMe) can improve the overall lung health of individuals who are infected with HIV and who do not respond adequately to anti- retroviral therapy. Approximately 35% of HIV-infected individuals do not recover their normal immune function even if they are adherent with anti-retroviral therapy and remain at high risk for pulmonary infections, chronic lung disease, and increased overall morbidity and mortality compared to individuals who achieve an immunological response. Although the mechanisms underlying this high failure rate are unknown, we have extensive empiric evidence from experimental and clinical studies that suggest that zinc deficiency and oxidative stress within the
airways play important roles, and that long-term dietary supplementation with zinc and SAMe can improve immune responses and overall lung health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
How HIV-related proteins increase the susceptibility to lung injury despite anti-retroviral therapy
-
批准号:10442363
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2019
-
负责人:David Marshall Guidot
-
依托单位:
Developing and testing novel therapies for the alcoholic lung: our clinical trials pipeline
-
批准号:9757650
-
项目类别:
-
资助金额:$30.43万
-
财政年份:2016
-
负责人:David Marshall Guidot
-
依托单位:
Immune enhancement for immunological non-responders to ART
-
批准号:8551693
-
项目类别:
-
资助金额:$44.59万
-
财政年份:2012
-
负责人:David Marshall Guidot
-
依托单位:
Zinc deficiency in the alcoholic lung
-
批准号:8497548
-
项目类别:
-
资助金额:$24.67万
-
财政年份:2010
-
负责人:David Marshall Guidot
-
依托单位:
Zinc deficiency in the alcoholic lung
-
批准号:8135196
-
项目类别:
-
资助金额:$26.52万
-
财政年份:2010
-
负责人:David Marshall Guidot
-
依托单位:
Zinc deficiency in the alcoholic lung
-
批准号:8299172
-
项目类别:
-
资助金额:$26.52万
-
财政年份:2010
-
负责人:David Marshall Guidot
-
依托单位:
Zinc deficiency in the alcoholic lung
-
批准号:8688850
-
项目类别:
-
资助金额:$25.73万
-
财政年份:2010
-
负责人:David Marshall Guidot
-
依托单位:
The mechanisms by which alcohol and HIV render the lung susceptible to injury
-
批准号:8597368
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:David Marshall Guidot
-
依托单位:
Zinc deficiency in the alcoholic lung
-
批准号:7985773
-
项目类别:
-
资助金额:$27.6万
-
财政年份:2010
-
负责人:David Marshall Guidot
-
依托单位:
The mechanisms by which alcohol and HIV render the lung susceptible to injury
-
批准号:7927721
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:David Marshall Guidot
-
依托单位:
The mechanisms by which alcohol and HIV render the lung susceptible to injury
-
批准号:8196334
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:David Marshall Guidot
-
依托单位:
The mechanisms by which alcohol and HIV render the lung susceptible to injury
-
批准号:8391588
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:David Marshall Guidot
-
依托单位:
RC#1: Alcohol and the Alveolar Epithelial Barrier
-
批准号:7555184
-
项目类别:
-
资助金额:$27.17万
-
财政年份:2009
-
负责人:David Marshall Guidot
-
依托单位:
Pilot Projects Component
-
批准号:7555191
-
项目类别:
-
资助金额:$12.74万
-
财政年份:2009
-
负责人:David Marshall Guidot
-
依托单位:
Administrative Core
-
批准号:7555181
-
项目类别:
-
资助金额:$14.33万
-
财政年份:2009
-
负责人:David Marshall Guidot
-
依托单位:
HIV-1 and ethanol-induced alveolar epithelial and macrophage dysfunction
-
批准号:7230826
-
项目类别:
-
资助金额:$19.37万
-
财政年份:2006
-
负责人:David Marshall Guidot
-
依托单位:
HIV-1 and ethanol-induced alveolar epithelial and macrophage dysfunction
-
批准号:7295812
-
项目类别:
-
资助金额:$15.67万
-
财政年份:2006
-
负责人:David Marshall Guidot
-
依托单位:
Emory Alcohol and Lung Biology Center
-
批准号:6701746
-
项目类别:
-
资助金额:$147.4万
-
财政年份:2003
-
负责人:David Marshall Guidot
-
依托单位:
Emory Alcohol and Lung Biology Center
-
批准号:6840869
-
项目类别:
-
资助金额:$172.24万
-
财政年份:2003
-
负责人:David Marshall Guidot
-
依托单位:
Emory Alcohol and Lung Biology Center
-
批准号:7167162
-
项目类别:
-
资助金额:$172.89万
-
财政年份:2003
-
负责人:David Marshall Guidot
-
依托单位:
海外基金